Surgical Robotics & Smart ORs for Mid-Sized Hospitals | MedTech World North America 2026
Why It Matters
Robotic surgery’s rapid diffusion and cost‑pressures will force midsize hospitals to rethink capital strategy, while interoperable, affordable platforms could democratize advanced procedures across outpatient settings.
Key Takeaways
- •Global robotic surgery share remains low at 6% of procedures.
- •U.S. robotic use at 26% projected to exceed 60% in decade.
- •Competition drives innovation, lowering costs and expanding ASC adoption.
- •Value hinges on total cost of ownership, not just purchase price.
- •Interoperable robotic ecosystems will shape future operating rooms.
Summary
The panel at MedTech World NA 2026 examined how surgical robotics and smart ORs are evolving for midsize hospitals and ambulatory surgery centers.
Speakers highlighted that only 6% of global surgeries use robots, but U.S. share is 26% and expected to surpass 60% within ten years, driving a $9 billion market growing above 15% annually. Competition has exploded from a single dominant player to over a hundred vendors, spurring innovation in AI, modular designs, and ASC‑focused platforms such as bone‑cutting robots for joint replacement.
Raj from Metronic noted “competition is good for patients,” while a VC emphasized reimbursement shifts enabling robotic procedures in outpatient settings. Clinicians stressed ergonomic benefits, 3‑D visualization, and reduced surgeon fatigue, yet cautioned that for short, simple cases the robot adds time and cost without clear outcome gains.
The discussion underscored that adoption will depend on total cost of ownership, flexible financing, and interoperable ecosystems that allow incremental upgrades. As pricing pressure mounts and lower‑cost platforms emerge, midsize hospitals and ASCs could achieve broader access, reshaping surgical care delivery.
Comments
Want to join the conversation?
Loading comments...